| mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0015 |
1 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.0012 |
1 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
| mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.001 |
1 |
| mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.00096 |
1 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0008 |
1 |